Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

Condition(s) studied

Investigational drug(s) / intervention(s)

Chlorhexidine Dressing: Transparent catheter cover with Chlorhexidine (3M™ CHG Tegaderm™)

Study summary

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections".

These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.

Eligibility

Primary outcome measure(s)

• Central line-associated bloodstream infections — during the intervention, up to 1 years
  defined as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection

Trial sites (1)

More Dokuz Eylul University trials in Turkey

Other trials for the same condition